Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses

BMC Bioinformatics

Volumn 12, Issue SUPPL. 1, 2011, Pages

  Huang, Jhang Wei ^a   Yang, Jinn Moon ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RECOGNITION; BIOLOGICAL INSIGHT; CONFORMATION CHANGE; CRITICAL POSITIONS; GENETIC DIVERSITY; NEUTRALIZING ANTIBODIES; RECEPTOR BINDING SITE; VACCINE DEVELOPMENT;

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BIOLOGY; VACCINES; VIRUSES; BIOINFORMATICS;

EPITOPES;

INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ARTICLE; BIOLOGICAL MODEL; GENETIC VARIABILITY; GENETICS; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA VIRUS A H3N2; MOLECULAR EVOLUTION; MUTATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES; EVOLUTION, MOLECULAR; GENETIC VARIATION; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MODELS, BIOLOGICAL; MUTATION;

EID: 79951528067     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-S1-S31     Document Type: Article

References (22)

1. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008, 26(Suppl 4):D31-D34. 10.1016/j.vaccine.2008.07.078, 19230156.
2. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science 1999, 286(5446):1921-1925. 10.1126/science.286.5446.1921, 10583948.
3. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305(5682):371-376. 10.1126/science.1097211, 15218094.
4. Lee MS, Chen JS. Predicting antigenic variants of influenza A/H3N2 viruses. Emerging infectious diseases 2004, 10(8):1385-1390.
5. Huang JW, King CC, Yang JM. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics 2009, 10(Suppl 1):S41. 2648776, 19208143, 10.1186/1471-2105-10-S1-S41.
6. Plotkin JB, Dushoff J, Levin SA. Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(9):6263-6268. 122937, 11972025, 10.1073/pnas.082110799.
7. Taylor HP, Dimmock NJ. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor. Virology 1994, 205(1):360-363. 10.1006/viro.1994.1653, 7975232.
8. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology 1990, 8:737-771. 10.1146/annurev.iy.08.040190.003513, 2188678.
9. Gupta V, Earl DJ, Deem MW. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 2006, 24(18):3881-3888. 10.1016/j.vaccine.2006.01.010, 16460844.
10. WHO Weekly Epidemiological Record. 2007, 45, 46, 48, 49, 50, 51, 52, 55, 57, 58, 60, 61, 62, 63, 65, 66, 67, 68, 69, 70, 71, 73, 74, 78, 79, 80, 71, 82., WHO.
11. Centers for Disease Control and Prevention Information for the Vaccines and Related Biological Products Advisory Committee, CBER, FDA. 2007, p. 28, p.18, p.19, p.17, Centers for Disease Control and Prevention.
12. Ellis JS, Chakraverty P, Clewley JP. Genetic and antigenic variation in the haemagglutinin of recently circulating human influenza A (H3N2) viruses in the United Kingdom. Archives of virology 1995, 140(11):1889-1904. 10.1007/BF01322680, 7503689.
13. Both GW, Sleigh MJ, Cox NJ, Kendal AP. Antigenic Drift in Influenza Virus-H3 Hemagglutinin from 1968 to 1980 - Multiple Evolutionary Pathways and Sequential Amino-Acid Changes at Key Antigenic Sites. Journal of Virology 1983, 48(1):52-60. 255321, 6193288.
14. Coiras MT, Aguilar JC, Galiano M, Carlos S, Gregory V, Lin YP, Hay A, Perez-Brena P. Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in Spain from 1996 to 2000. Archives of virology 2001, 146(11):2133-2147. 10.1007/s007050170025, 11765916.
15. Webster R, Cox NJ, Stohr K. WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO/CDS/CSR/NCS/20025 2002, Rev.1.
16. Bao YM, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D. The influenza virus resource at the national center for biotechnology information. Journal of Virology 2008, 82(2):596-601. 2224563, 17942553, 10.1128/JVI.02005-07.
17. Macken C, Lu H, Goodman J, Boykin L. The value of a database in surveillance and vaccine selection. Options for the Control of Influenza Iv 2001, 1219:103-106.
18. Knossow M, Gaudier M, Douglas A, Barrere B, Bizebard T, Barbey C, Gigant B, Skehel JJ. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 2002, 302(2):294-298. 10.1006/viro.2002.1625, 12441073.
19. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 2002, 294(1):70-74. 10.1006/viro.2001.1320, 11886266.
20. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bosecke P, Wharton SA, Skehel JJ, Knossow M. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 1995, 376(6535):92-94. 10.1038/376092a0, 7596443.
21. Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, Knossow M. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nature Structural Biology 1999, 6(6):530-534. 10.1038/9299, 10360354.
22. Ndifon W, Wingreen NS, Levin SA. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(21):8701-8706. 2688967, 19439657, 10.1073/pnas.0903427106.